Mandate

Vinge advises Bridgepoint on the acquisition of Ports Group

August 31, 2023

Vinge is advising Bridgepoint Development Capital ("Bridgepoint") in connection with the acquisition of House of Ports Holding AB ("Ports Group").

Ports Group is a fast growing and profitable platform-based provider of IP and domain services. Ports Group has a unique position in the market with 25 years of experience in digitalisation as an ICANN-accredited registrar and a comprehensive Brand Protection package including software and services within Domain Management, Trademark Management and Web Security. Proactive protection through Ports Group's monitoring services secures the customer's intellectual property and exclusive rights. Central to what Ports offers is the Ports Management software platform, which brings together the portfolio of holdings, providing an optimal overview and automated management. The platform manages domains, trademarks and web security products.

Vinge's team consisted of Daniel Rosvall, Samra Tesser, Ellen Flygt, Michella Lina Said and Elis Allmark (M&A), Louise Brorsson Salomon, Josefine Lanker, Jolinn Uhlin, David Flodin, Nour Makie (Banking and Finance), Mathilda Persson, Mika Jordan and Jolene Reimerson (IT and GDPR), Mario Saad (Commercial), Julia Löfqvist (Compliance), Alexandra Tamm (Real Estate), David Olander (EU and Competition), and Cecilia Loctander (Project Assistant).

 

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025